Bayer

Steep drop in medical device reports on Bayer's Essure in 2021, FDA data show
Medtech Dive
Wed, 03/16/22 - 10:28 am
devices
Medtech
Bayer
Essure
contraceptives
Amid inflation spike, execs at J&J, Bayer, GSK and more talk higher costs—and what it means for profits
Fierce Pharma
Fri, 03/11/22 - 11:06 am
inflation
JNJ
Bayer
GSK
Viatris
With Bayer's new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long?
Fierce Pharma
Tue, 03/1/22 - 10:04 pm
Bayer
Eylea
Xarelto
drug launches
Kodiak's Eylea rival hits 'major disappointment' with failure in first of 6 phase 3 studies
Fierce Biotech
Wed, 02/23/22 - 09:28 pm
Kodiak Sciences
KSI-301
Eylea
Bayer
Regeneron
Bayer hikes Nubeqa's peak sales to more than €3B on prostate cancer data, teeing up new 3-way battle against Pfizer-Astellas, J&J
Fierce Pharma
Fri, 02/18/22 - 10:35 am
Bayer
Nubeqa
prostate cancer
Latest data on Bayer's Essure show more patients had device removed: FDA
Medtech Dive
Tue, 02/15/22 - 10:43 am
Bayer
Essure
devices
patients
contraceptives
Medtech
FDA
Bayer-owned AskBio will shift focus toward its doggybone DNA in restructure with Touchlight
Endpoints
Wed, 02/9/22 - 10:47 pm
AskBio
Bayer
DNA
dbDNA
Touchlight
Bayer-led project on AI in trials eyes ‘virtual’ placebo groups
Pharmaforum
Fri, 02/4/22 - 12:53 pm
Bayer
placebos
artificial intelligence
clinical trials
Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets
BioSpace
Fri, 02/4/22 - 11:09 am
Bayer
Evotec
BAY1817080
eliapixant
Roche grabs FDA okay for would-be blockbuster eye drug faricimab
Pharmaforum
Mon, 01/31/22 - 10:51 am
Roche
faricimab
Eylea
Bayer
Regeneron
FDA
Backed by Bayer's Leaps, Boston-based Cellino lands $80M for cell therapy-in-box
Endpoints
Tue, 01/25/22 - 10:48 am
Cellino
funding
Bayer
cell therapy
regenerative medicine
Bayer jumps on board Mammoth's ultra-small CRISPR tech with sights set first on liver disease
Endpoints
Mon, 01/10/22 - 11:28 am
Bayer
CRISPR
Jennifer Doudna
Mammoth Biosciences
Bayer Commits to 100 Percent Green Packaging by 2030
Xtalks
Wed, 12/29/21 - 11:09 am
Bayer
environmental concerns
packaging
Bayer targets 100% green packaging for consumer health brands by 2030 as part of €100 million sustainability plan
Fierce Pharma
Tue, 12/14/21 - 11:19 am
Bayer
environmental concerns
consumer health
sustainability
Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer
Pharmaforum
Fri, 12/3/21 - 10:33 am
Bayer
Nubeqa
castration-resistant prostate cancer
prostate cancer
clinical trials
Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect
Fierce Biotech
Tue, 11/30/21 - 10:41 am
MEI Pharma
blood cancer
follicular lymphoma
zandelisib
Bayer
Gilead Sciences
Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models
Fierce Biotech
Fri, 11/5/21 - 09:49 am
Parkinson's Disease
Levodopa
gene therapy
Voyager Therapeutics
Bayer
Synbio startup GRObio gets $25M to work with new building blocks for protein drugs
MedCity News
Wed, 11/3/21 - 11:31 pm
GRObio
Harvard
funding
Bayer
protein therapeutics
Bayer, One Drop launch AI tool for heart disease prevention
Pharmaforum
Wed, 10/27/21 - 11:39 pm
Bayer
One Drop
digital health
artificial intelligence
cardiovascular disease
Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report
Endpoints
Fri, 10/15/21 - 10:57 am
CureVac
Bayer
vaccines
COVID-19
MRNA
drug manufacturing

Pages